Polyrizon Achieves Key Manufacturing Milestone for Its Intranasal Allergy Protection Platform
Successful scale-up of PL-14 production paves the way for 2026 clinical trials and future commercial readiness. Polyrizon (PLRZ), a biotechnology ...
Successful scale-up of PL-14 production paves the way for 2026 clinical trials and future commercial readiness. Polyrizon (PLRZ), a biotechnology ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?